You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

Transcatheter Arterial Chemoembolization

Showing 1 - 25 of 6,540
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Hepatocellular Carcinoma Trial in Guangzhou (Bevacizumab combined with Sintilimab, Transcatheter arterial chemoembolization)

Recruiting
  • Hepatocellular Carcinoma
  • Bevacizumab combined with Sintilimab
  • Transcatheter arterial chemoembolization
  • Guangzhou, Guangdong, China
    Sun Yat-Sen University Cancer Center
Oct 14, 2023

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Nanjing (Oxycodone, Sufentanil)

Recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Nanjing, Jiangsu, China
    The First Affiliated Hospital with Nanjing Medical University
Sep 15, 2023

Patterns of Transcatheter Arterial Chemoembolization Combined

Not yet recruiting
  • HCC
  • (no location specified)
Aug 29, 2023

Hepatocellular Carcinoma Trial (TACE(transcatheter arterial chemoembolization), lenvatinib, Icaritin soft capsules)

Not yet recruiting
  • Hepatocellular Carcinoma
  • TACE（transcatheter arterial chemoembolization）
  • +2 more
  • (no location specified)
Jun 5, 2023

Hepatocellular Carcinoma, Transcatheter Arterial ChEmoembolization, Regorafenib Trial in Guangzhou (TACE, Regorafenib)

Recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Guangzhou, Guangdong, China
    FirstSunYetSen
Apr 12, 2023

Hepatocellular Carcinoma, Transcatheter Arterial Chemoembolization, Pain Trial in Chongqing (Esketamine, Sufentanil)

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jan 2, 2023

Tumor Micronecrosis on Postoperative Transcatheter Arterial

Completed
  • Carcinoma, Hepatocellular
  • transcatheter arterial chemoembolization
  • Hangzhou, Zhejiang, China
    the First Affiliated Hospital, Zhejiang University School of Med
Apr 22, 2022

Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Tumors Germ Cell and Embryonal Tumors by Histologic Type Tumors Tumors

Not yet recruiting
  • Melanoma Neuroendocrine Tumors Neuroectodermal Tumors Neoplasms Germ Cell and Embryonal Neoplasms by Histologic Type Neoplasms Neoplasms
  • HX008 + TACE
  • +2 more
  • Beijing, Beijing, China
    Beijing Cancer hospital
Dec 8, 2022

Hepatocellular Carcinoma Trial in Seoul (Nexsphere™)

Recruiting
  • Hepatocellular Carcinoma
  • Nexsphere™
  • Seoul, Korea, Republic of
    Asan Medical Center
Apr 1, 2022

Advanced Gastric Cancer Trial in Shanghai (Transcatheter Arterial Chemoembolization, Tislelizumab)

Recruiting
  • Advanced Gastric Cancer
  • Shanghai, Shanghai, China
    ZhongShan hospital Fudan university
May 25, 2022

Colorectal Cancer Liver Metastasis Trial (Irinotecan and polyvinyl alcohol sodium acrylate embolization

Not yet recruiting
  • Colorectal Cancer Liver Metastasis
  • Irinotecan and polyvinyl alcohol sodium acrylate embolization microspheres（Unipearls®）
  • Irinotecan and HepaSphere Microspheres
  • (no location specified)
Aug 31, 2023

Hepatocellular Carcinoma Trial in Hangzhou (Fruquintinib, Sintilimab, Transcatheter arterial chemoembolization(TACE))

Recruiting
  • Hepatocellular Carcinoma
  • Hangzhou, Zhejiang, China
    Guoliang Shao
Aug 1, 2023

Advanced Hepatocellular Carcinoma Trial in Chengdu (Lenvatinib combined with TACE and Camrelizumab)

Recruiting
  • Advanced Hepatocellular Carcinoma
  • Lenvatinib combined with TACE and Camrelizumab
  • Chengdu, Sichuan, China
    HuaXi hospital
Feb 12, 2023

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (TACE combined with lenvatinib and sintilimab)

Completed
  • Hepatocellular Carcinoma Non-resectable
  • TACE combined with lenvatinib and sintilimab
  • Guangzhou, Guangdong, China
    The Second Affiliated Hospital of Guangzhou Medical University
Nov 8, 2022

Hepatocellular Carcinoma, Hepatic Portal Vein Tumor Invasion, Tumor Thrombus Trial (I-125 Seeds Brachytherapy in PVTT,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • I-125 Seeds Brachytherapy in PVTT
  • +2 more
  • (no location specified)
Aug 14, 2023

Hepatocellular Carcinoma Non-resectable Trial in Guangzhou (TACE combined with sorafenib and tislelizumab)

Completed
  • Hepatocellular Carcinoma Non-resectable
  • TACE combined with sorafenib and tislelizumab
  • Guangzhou, Guangdong, China
  • +1 more
Oct 11, 2022

Hepatocellular Carcinoma Trial in Houston (Lenvatinib, Transcatheter Arterial Chemoembolization)

Not yet recruiting
  • Hepatocellular Carcinoma
  • Houston, Texas
    Houston Methodist Research Institute
Dec 10, 2021

Hepatocellular Carcinoma Trial in Shanghai (Sintilimab, TACE)

Recruiting
  • Hepatocellular Carcinoma
  • Shanghai, China
    Fudan University Shanghai Cancer Center
May 30, 2022

Hepatocellular Carcinoma, Transarterial Chemoembolization, Hepatic Arterial Infusion Chemo Trial in Chongqing (Esketamine,

Not yet recruiting
  • Hepatocellular Carcinoma
  • +3 more
  • Chongqing, Chongqing, China
    The Second Affiliated Hospital, Chongqing Medical University
Jun 9, 2022

Hepatocellular Carcinoma Trial in Hershey (Lumason)

Completed
  • Hepatocellular Carcinoma
  • Hershey, Pennsylvania
    Penn State Hershey Medical Center
Oct 17, 2022

Comparison of Efficacy in SBRT of HCC =5 cm With or Without TACE

Recruiting
  • Small Hepatocellular Carcinoma
  • +2 more
  • transcatheter arterial chemoembolization
  • Beijing, China
    The Fifth Medical Center of PLA General Hospital (Beijing 302 ho
Sep 12, 2021

Hepatocellular Carcinoma, TACE, Anlotinib Trial in Lanzhou, Xi'an (Anlotinib Hydrochloride, TACE)

Active, not recruiting
  • Hepatocellular Carcinoma
  • +2 more
  • Anlotinib Hydrochloride
  • TACE
  • Lanzhou, Gansu, China
  • +3 more
Jan 12, 2023

Radiomics, Hepatocellular Carcinoma (HCC), Transcatheter Arterial Chemoembolization (TACE) Trial in Guangzhou (Sorafenib,

Active, not recruiting
  • Radiomics
  • +4 more
  • Guangzhou, Guangdong, China
    The First Affiliated Hospital of Sun Yat-sen University
Jun 5, 2023

Comparison of Efficacy in SBRT of Large HCC With or Without TACE

Recruiting
  • Large HCC Patients
  • +2 more
    • Beijing, China
      Beijing 302 hospital
    Sep 12, 2021

    Hepatocellular Carcinoma Trial in Shanghai (lenvatinib, TACE)

    Active, not recruiting
    • Hepatocellular Carcinoma
    • Shanghai, China
      Huashan hospital
    Jul 29, 2022